AMPE Ampio Pharmaceuticals Inc

Price (delayed)

$1.8

Market cap

$360.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$341.05M

Ampio Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company primarily engaged in the development of AmpionTM, its lead anti-inflammatory drug, which is currently undergoing clinical trials focused on the treatment ...

Highlights
The company's debt fell by 28% YoY and by 9% QoQ
Ampio Pharmaceuticals's equity has increased by 21% from the previous quarter
The net income is up by 6% year-on-year but it has declined by 6% since the previous quarter
The quick ratio has decreased by 34% QoQ

Key stats

What are the main financial stats of AMPE
Market
Shares outstanding
200.46M
Market cap
$360.82M
Enterprise value
$341.05M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
17.3
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$15.21M
EBITDA
-$14.05M
Free cash flow
-$12.21M
Per share
EPS
-$0.08
Free cash flow per share
-$0.06
Book value per share
$0.1
Revenue per share
$0
TBVPS
$0.14
Balance sheet
Total assets
$26.71M
Total liabilities
$6.35M
Debt
$773,000
Equity
$20.36M
Working capital
$19.67M
Liquidity
Debt to equity
0.04
Current ratio
7.08
Quick ratio
6.35
Net debt/EBITDA
1.41
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-70%
Return on equity
-93.1%
Return on invested capital
-325%
Return on capital employed
-64.8%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMPE stock price

How has the Ampio Pharmaceuticals stock price performed over time
Intraday
5.88%
1 week
20%
1 month
31.39%
1 year
89.47%
YTD
13.21%
QTD
7.78%

Financial performance

How have Ampio Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$14.71M
Net income
-$15.21M
Gross margin
N/A
Net margin
N/A
Ampio Pharmaceuticals's operating income has increased by 30% YoY but it has decreased by 8% QoQ
The net income is up by 6% year-on-year but it has declined by 6% since the previous quarter

Growth

What is Ampio Pharmaceuticals's growth rate over time

Valuation

What is Ampio Pharmaceuticals stock price valuation
P/E
N/A
P/B
17.3
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 20% year-on-year
Ampio Pharmaceuticals's equity has increased by 21% from the previous quarter

Efficiency

How efficient is Ampio Pharmaceuticals business performance
The ROE has soared by 73% year-on-year and by 17% since the previous quarter
The return on assets has increased by 45% year-on-year and by 12% since the previous quarter
Ampio Pharmaceuticals's return on invested capital has decreased by 16% QoQ

Dividends

What is AMPE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMPE.

Financial health

How did Ampio Pharmaceuticals financials performed over time
The current ratio has soared by 165% YoY but it has contracted by 34% from the previous quarter
The company's total assets has surged by 125% YoY and by 23% QoQ
The company's debt is 96% lower than its equity
AMPE's debt to equity has dropped by 76% year-on-year and by 20% since the previous quarter
The company's debt fell by 28% YoY and by 9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.